Literature DB >> 16476993

Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay.

Suzanne U Emerson1, Pilar Clemente-Casares1, Nasser Moiduddin1, Vidya A Arankalle2, Udana Torian1, Robert H Purcell1.   

Abstract

Monolayers of Hep G2/C3A cells were inoculated with genotype 1 Hepatitis E virus (HEV) mixed with either anti-HEV or an appropriate control. After 5 or 6 days, cell monolayers were stained with anti-HEV and infected cells were identified by immunofluorescence microscopy and counted. Anti-HEV from vaccinated or infected rhesus monkeys neutralized the virus, as did mAbs that recognized epitopes on the C terminus of a recombinant vaccine protein. Antibodies were broadly cross-reactive, since convalescent serum from animals infected with any one of the four mammalian genotypes all neutralized the genotype 1 virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476993     DOI: 10.1099/vir.0.81545-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

Review 1.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 3.  Development of new hepatitis E vaccines.

Authors:  Yufeng Cao; Zhenhong Bing; Shiyu Guan; Zecai Zhang; Xinping Wang
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

4.  Branched-linear and agglomerate protein polymers as vaccine platforms.

Authors:  Leyi Wang; Ming Xia; Pengwei Huang; Hao Fang; Dianjun Cao; Xiang-Jin Meng; Monica McNeal; Xi Jiang; Ming Tan
Journal:  Biomaterials       Date:  2014-06-28       Impact factor: 12.479

5.  CD8+ lymphocytes but not B lymphocytes are required for protection against chronic hepatitis E virus infection in chickens.

Authors:  Eda Rogers; Stephanie Michelle Todd; Frank William Pierson; Scott P Kenney; Connie Lynn Heffron; Danielle M Yugo; Shannon R Matzinger; Elena Mircoff; Irene Ngo; Charles Kirby; Michaela Jones; Paul Siegel; Peter Jobst; Karen Hall; Robert J Etches; Xiang-Jin Meng; Tanya LeRoith
Journal:  J Med Virol       Date:  2019-07-25       Impact factor: 2.327

Review 6.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

7.  Serological evidence for a hepatitis e virus-related agent in goats in the United States.

Authors:  B J Sanford; S U Emerson; R H Purcell; R E Engle; B A Dryman; T E Cecere; V Buechner-Maxwell; D P Sponenberg; X J Meng
Journal:  Transbound Emerg Dis       Date:  2012-08-22       Impact factor: 5.005

8.  Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.

Authors:  Brenton J Sanford; Tanja Opriessnig; Scott P Kenney; Barbara A Dryman; Laura Córdoba; Xiang-Jin Meng
Journal:  Vaccine       Date:  2012-08-17       Impact factor: 3.641

9.  A dual vaccine candidate against norovirus and hepatitis E virus.

Authors:  Leyi Wang; Dianjun Cao; Chao Wei; Xiang-Jin Meng; Xi Jiang; Ming Tan
Journal:  Vaccine       Date:  2013-11-27       Impact factor: 3.641

10.  Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure.

Authors:  Tetsuo Yamashita; Yoshio Mori; Naoyuki Miyazaki; R Holland Cheng; Masato Yoshimura; Hideaki Unno; Ryoichi Shima; Kohji Moriishi; Tomitake Tsukihara; Tian Cheng Li; Naokazu Takeda; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.